Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure, featuring a piperidine ring protected by a tert-butyl carbamate group and substituted with a 1H-pyrazol-1-yl moiety at the 4-position, allows for easy modification of piperidine-based compounds, making it valuable in creating analogs for drug discovery. The Boc protecting group facilitates selective reactions and is readily removable. Commonly employed in the preparation of kinase inhibitors and receptor modulators due to the pyrazole moiety, which is known for favorable binding interactions in biological systems. Also utilized in agrochemical research for designing novel active ingredients with improved selectivity and stability.